ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

11.46

-0.48 (-4.02%)

At close: Oct 15, 2026, 4:00 PM EDT

11.45

-0.01 (-0.09%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Assets	$1.95M
Expense Ratio	0.95%
PE Ratio	n/a
Forward PE	n/a
Shares Out	165,519
Dividend	$0.62 (5.39%)
Ex-Dividend Date	Sep 23, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	13,502
Open	11.50
Previous Close	11.94
Day's Range	11.34 - 11.55
52-Week Low	10.51
52-Week High	23.70
Beta	-1.17
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange Nasdaq

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-200.55% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-25.72%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-38.23%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-44.14%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-45.88%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-46.58%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Sep 23, 2026	$0.13889	Sep 29, 2026
Jun 24, 2026	$0.1366	Jun 30, 2026
Mar 25, 2026	$0.13714	Mar 31, 2026
Dec 24, 2025	$0.20514	Dec 31, 2025
Sep 24, 2025	$0.30854	Sep 30, 2025
Jun 25, 2025	$0.2161	Jul 1, 2025

Full Dividend History

Performance

BIS had a total return of -50.40% in the past year, including dividends. Since the fund's inception, the average annual return has been -32.92%.